Is State Street SPDR S&P Biotech ETF ( XBI ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Top 3 Genomics Stocks to Consider for Your Portfolio
Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.
CRISPR Therapeutics AG ( CRSP ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
Cathie Dumps AMD And Reddit Shares Amid Tech Bloodbath, Ark Doubles Down On Tom Lee And Peter Thiel Crypto Plays - Advanced Micro Devices ( NASDAQ:AMD )
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably involving Circle Internet Group Inc ( NYSE:CRCL ) , Bitmine Immersion Technologies Inc ( NYSE:BMNR ) , Bullish ( NYSE:BLSH ) , Advanced Micro Devices Inc ( NASDAQ:AMD ) , and Reddit Inc ( NYSE:RDDT ) .
ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?
On Nov. 12, 2025, ARK Investment Management disclosed in an SEC filing that it reduced its stake in CRISPR Therapeutics AG ( NASDAQ:CRSP ) by approximately 400,000 shares.According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold ...
Cathie Wood Goes Big On Alibaba With $25 Million Share Purchase, Scales Back On This Social Media Stock - Alibaba Gr Hldgs ( NYSE:BABA )
On Tuesday, Cathie Wood-led Ark Invest made significant moves in its portfolio, focusing on Alibaba Group Holding Ltd. ( NASDAQ:BABA ) , Baidu Inc. ( NASDAQ:BIDU ) , and Reddit Inc. ( NYSE:RDDT ) . These trades come amid a backdrop of evolving market dynamics and regulatory challenges, ...
CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial - CRISPR Therapeutics ( NASDAQ:CRSP )
On Saturday, CRISPR Therapeutics AG ( NASDAQ:CRSP ) shared Phase 1 data from its ongoing clinical trial evaluating CTX310, an investigational, in vivo CRISPR/Cas9 gene-editing therapy targeting ANGPTL3.
CRSP Posts Narrower-Than-Expected Loss in Q3, Sales Miss Estimates
CRISPR Therapeutics posts a narrower-than-expected Q3 loss, trims R&D spend, and advances late-stage and next-gen gene-editing programs.
Cathie Wood Dumps $2.4 Million Worth Of Tesla Stock, Doubles Down On These AI Stocks - Tesla ( NASDAQ:TSLA )
On Monday, Cathie Wood-led Ark Invest executed significant trades involving Tesla Inc. ( NASDAQ:TSLA ) , Pony AI Inc. ( NASDAQ:PONY ) , Taiwan Semiconductor Manufacturing Co. Ltd. ( NYSE:TSM ) , and Baidu Inc. ( NASDAQ:BIDU ) . These trades highlight Ark's strategic positioning in the tech and AI ...
Cathie Wood Dumps $2.4 Million Worth Of Tesla Shares, Doubles Down On These AI Stocks - Tesla ( NASDAQ:TSLA )
On Monday, Cathie Wood-led Ark Invest executed significant trades involving Tesla Inc. ( NASDAQ:TSLA ) , Pony AI Inc. ( NASDAQ:PONY ) , Taiwan Semiconductor Manufacturing Co. Ltd. ( NYSE:TSM ) , and Baidu Inc. ( NASDAQ:BIDU ) . These trades highlight Ark's strategic positioning in the tech and AI ...
CRISPR Therapeutics AG ( CRSP ) Reports Q3 Loss, Lags Revenue Estimates
CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +11.36% and -86.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering
-Data presented in a late-breaking presentation at the American Heart Association ( AHA ) Scientific Sessions ...
CRISPR Therapeutics AG ( CRSP ) Stock Drops Despite Market Gains: Important Facts to Note
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16, representing a -2.56% change from its previous close.
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys - Bullish ( NYSE:BLSH )
On Tuesday, Cathie Wood-led Ark Invest made several significant trades, with the most notable being the purchase of shares in Bullish ( NYSE:BLSH ) . Ark Invest's primary trade of the day was in Bullish, a cryptocurrency exchange backed by billionaire investor and entrepreneur Peter Thiel.
CRISPR Therapeutics AG ( CRSP ) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
CRISPR Therapeutics AG ( CRSP ) Stock Moves -2.51%: What You Should Know
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $62.56, representing a -2.51% change from its previous close.
Urogen Pharma ( URGN ) Expected to Beat Earnings Estimates: Should You Buy?
Urogen Pharma (URGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CRISPR Therapeutics AG ( CRSP ) Expected to Beat Earnings Estimates: Should You Buy?
CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CRISPR Therapeutics AG ( CRSP ) Laps the Stock Market: Here's Why
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $67.21, denoting a +1.04% move from the preceding trading day.
CRISPR Therapeutics AG ( CRSP ) Stock Moves -2.24%: What You Should Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $72.31, marking a -2.24% move from the previous day.
Investors Heavily Search CRISPR Therapeutics AG ( CRSP ) : Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
CRISPR Therapeutics AG ( CRSP ) Stock Sinks As Market Gains: What You Should Know
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $68.29, indicating a -6.54% shift from the previous trading day.
CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency ( AATD ) Utilizing Novel SyNTase™ Editing Platform
-Preclinical data presented at the European Society of Gene and Cell Therapy ( ESGCT ) highlight a potential ...
CRISPR Therapeutics AG ( CRSP ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $74.89, moving 2.46% from the previous trading session.
CRISPR Therapeutics ( CRSP ) Surges 8.7%: Is This an Indication of Further Gains?
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Here is What to Know Beyond Why CRISPR Therapeutics AG ( CRSP ) is a Trending Stock
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics AG ( CRSP ) Stock Falls Amid Market Uptick: What Investors Need to Know
CRISPR Therapeutics AG (CRSP) reached $67.74 at the closing of the latest trading day, reflecting a -6.98% change compared to its last close.
CRISPR Therapeutics AG ( CRSP ) Laps the Stock Market: Here's Why
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $61.67, marking a +2.24% move from the previous day.
CRISPR Therapeutics AG ( CRSP ) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $60.62, marking a -2.38% move from the previous day.
Is Trending Stock CRISPR Therapeutics AG ( CRSP ) a Buy Now?
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics ( NASDAQ: CRSP ) , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Sirius Therapeutics, a clinical stage biotech company ...
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe - CRISPR Therapeutics ( NASDAQ:CRSP )
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Sirius Therapeutics, a clinical stage biotech company developing ...
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025
GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.
Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood - Dumps Kratos Defense Amid Taiwan Drone Buzz - ARK Autonomous Technology & Robotics ETF ( BATS:ARKQ ) , ARK Innovation ETF ( BATS:ARKK )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Bullish BLSH, Kratos Defense and Security Solutions Inc. KTOS, Pony AI Inc. PONY, and Robinhood Markets Inc. HOOD.
CRISPR Therapeutics AG ( CRSP ) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $59.07, marking a -3.46% move from the previous day.
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI - Grayscale Bitcoin Mini Trust ( BTC ) Common units of fractional undivided beneficial interest ( ARCA:BTC )
On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. AMD and Bullish Inc. BLSH, while selling shares of Tempus AI Inc. TEM. Additionally, Ark purchased Figma Inc. FIG stock, reflecting strategic adjustments in its investment ...
CRISPR Therapeutics AG ( CRSP ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wall Street Analysts See CRISPR Therapeutics ( CRSP ) as a Buy: Should You Invest?
Based on the average brokerage recommendation (ABR), CRISPR Therapeutics (CRSP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRISPR Therapeutics AG ( CRSP ) Stock Slides as Market Rises: Facts to Know Before You Trade
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $51.81, indicating a -3.5% shift from the previous trading day.
CRISPR Therapeutics ( CRSP ) Down 5.3% Since Last Earnings Report: Can It Rebound?
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CRISPR Therapeutics AG ( CRSP ) Is a Trending Stock: Facts to Know Before Betting on It
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Cathie Wood's Raises Wager On Ethereum-Hoarding Bitmine: Ark Buys Stock Of Tom Lee-Backed Company, Dumps Shares Of Sports Betting Giant - Grayscale Bitcoin Mini Trust ( BTC ) Common units of fractional undivided beneficial interest ( ARCA:BTC )
Ark Invest, led by Cathie Wood, executed significant trades on Wednesday, focusing on Bitmine Immersion Technologies Inc. BMNR and DraftKings Inc. DKNG.
Cathie Wood's $21 Million Tuesday Move: Peter Thiel's Crypto Play Gets Boost In Ark Portfolio - Grayscale Bitcoin Mini Trust ( BTC ) Common units of fractional undivided beneficial interest ( ARCA:BTC )
Cathie Wood-led Ark Invest made significant trades on Tuesday with notable activity in Bullish BLSH, Robinhood Markets Inc. HOOD, and Tempus AI Inc. TEM. ArrivedBuy shares of homes and vacation rentals for as little as $100. Get Started
Investors Heavily Search CRISPR Therapeutics AG ( CRSP ) : Here is What You Need to Know
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Cathie Wood's 'Apocalypse Squad' Play? Ark Scoops Up $14.2 Million Worth Of Robinhood Stock - ARK Autonomous Technology & Robotics ETF ( BATS:ARKQ ) , ARK Innovation ETF ( BATS:ARKK )
Ark Invest, led by Cathie Wood, executed notable trades on Monday, focusing on Robinhood Markets Inc. HOOD and Deere & Co. DE. ArrivedBuy shares of homes and vacation rentals for as little as $100. Get Started Interactive BrokersTrade global markets with low costs and pro-level tools at ...
Cathie Wood Bets $19 Million More On Jack Dorsey's Block Amid Bitcoin's All-Time High Push, Dumps Shopify Stock - ARK Fintech Innovation ETF ( BATS:ARKF )
On Monday, Cathie Wood-led Ark Invest made significant trades involving Block Inc. XYZ and Shopify Inc. SHOP.
Here is What to Know Beyond Why CRISPR Therapeutics AG ( CRSP ) is a Trending Stock
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results - ARK Innovation ETF ( BATS:ARKK )
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. XYZ on Tuesday. The move comes just days before the company's much-anticipated second-quarter earnings, due on Thursday, and following its high-profile addition to the S&P 500.
CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption
CRISPR Therapeutics posts a wider second-quarter loss tied to Sirius deal costs, while Casgevy adoption gains momentum across global markets.
Cathie Wood Drops $8.3 Million On AMD And Nvidia In Monday Trading Blitz, Sells Robinhood Stock Amid 'Project Crypto' Buzz - ARK Fintech Innovation ETF ( BATS:ARKF ) , Advanced Micro Devices ( NASDAQ:AMD )
On Monday, Cathie Wood-led Ark Invest made significant trades involving Advanced Micro Devices Inc. AMD, NVIDIA Corp NVDA, and Robinhood Markets Inc HOOD. These trades highlight Ark's strategic positioning in the tech and financial sectors. ArrivedBuy shares of homes and vacation rentals for as ...
